2025 Q4 -tulosraportti
Vain PDF
27 päivää sitten
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 416 | - | - | ||
| 3 894 | - | - | ||
| 1 | - | - | ||
| 617 | - | - | ||
| 694 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 6.5.2025 | ||
2024 Q4 -tulosraportti 19.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenNanexa Discord is the only place this stock, to my knowledge, is discussed at a high and detailed level. And on an incredibly decent level. Thanks to our Swedish brother people for the good debate. If you want to debate, then write in English, it makes it easier and possibly use translate in your browser when reading. Danes are welcome - I myself have been incredibly well received. https://discord.com/channels/747545483072897115/
·1 päivä sittenDoes anyone know if there is a Nanexa discord or similar that is still alive?- ·13.3. · MuokattuInteresting 6mdr chart. Up +50-60% from old level. A certain plateau it's hovering around in, 3,5-3,7 looks like the support one can somewhat count on. until it goes either UP or DOWN as soon as there's something new under the sun. Worst case, 3,5 cannot hold because in 1 mdr there's still no new information announced. Buuuut. Yes. It is is pure gambling to stand outside the door and wait for it to go up by itself.
·13.3.It could well indicate that news is coming soon, because the short sellers are covering their positions. Now the short interest has fallen from 0.36% yesterday, to 0.19% today.
·12.3.A little communication with the CEO below. All good things come to those who wait. ---------- Date: Thursday, 12 March 2026 at 09:00 To: David Westberg david.westberg@nanexa.se Subject: Sema-3-månaders-PK, BIO-Europe Hi David, Will you issue a press release when the sema-3-month results are ready, as you did with the 1-month results, and do you see that the meetings at BIO-Europe will mostly be discussions with some of the selected companies you are currently discussing GLP-1 with or new acquaintances? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 9:18 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, I expect that we will send out a PM about it when we have data. At BIO it will be mixed. Both old and new companies. Discussions about GLP-1 are taking place in parallel with BIO. Regards David ---------- Date: Thursday, 12 March 2026 at 09:58 To: David Westberg david.westberg@nanexa.se Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, Thanks, would you say that the GLP-1 discussions are progressing satisfactorily at present? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 10:12 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe I would, as I have previously communicated Regards David·13.3.Novo's former chairman is also impatient - but it's about getting a really good deal, not the fastest: https://www.youtube.com/watch?v=mg0B2L8fFtU&t=1228s We are getting closer and closer.·13.3.I don't see the problem. The obesity/diabetes area is gigantic, and we know the company is intensively negotiating possibilities for both specific and broad platform agreements with Novo and at least one other player of the same size. Nanexa is financed until 2026 and confident they will get an agreement - in the first half of the year as indicated by the chairman of the board. There isn't long left. The goal is the best achievable of its kind in a unique market that will finance the company for many years to come. This will start a journey towards Nanexa being in a completely, completely different league in a few years via their unique technology. Think about how low the market capitalization is currently.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
27 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenNanexa Discord is the only place this stock, to my knowledge, is discussed at a high and detailed level. And on an incredibly decent level. Thanks to our Swedish brother people for the good debate. If you want to debate, then write in English, it makes it easier and possibly use translate in your browser when reading. Danes are welcome - I myself have been incredibly well received. https://discord.com/channels/747545483072897115/
- ·1 päivä sittenDoes anyone know if there is a Nanexa discord or similar that is still alive?
- ·13.3. · MuokattuInteresting 6mdr chart. Up +50-60% from old level. A certain plateau it's hovering around in, 3,5-3,7 looks like the support one can somewhat count on. until it goes either UP or DOWN as soon as there's something new under the sun. Worst case, 3,5 cannot hold because in 1 mdr there's still no new information announced. Buuuut. Yes. It is is pure gambling to stand outside the door and wait for it to go up by itself.
- ·13.3.It could well indicate that news is coming soon, because the short sellers are covering their positions. Now the short interest has fallen from 0.36% yesterday, to 0.19% today.
- ·12.3.A little communication with the CEO below. All good things come to those who wait. ---------- Date: Thursday, 12 March 2026 at 09:00 To: David Westberg david.westberg@nanexa.se Subject: Sema-3-månaders-PK, BIO-Europe Hi David, Will you issue a press release when the sema-3-month results are ready, as you did with the 1-month results, and do you see that the meetings at BIO-Europe will mostly be discussions with some of the selected companies you are currently discussing GLP-1 with or new acquaintances? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 9:18 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, I expect that we will send out a PM about it when we have data. At BIO it will be mixed. Both old and new companies. Discussions about GLP-1 are taking place in parallel with BIO. Regards David ---------- Date: Thursday, 12 March 2026 at 09:58 To: David Westberg david.westberg@nanexa.se Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, Thanks, would you say that the GLP-1 discussions are progressing satisfactorily at present? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 10:12 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe I would, as I have previously communicated Regards David·13.3.Novo's former chairman is also impatient - but it's about getting a really good deal, not the fastest: https://www.youtube.com/watch?v=mg0B2L8fFtU&t=1228s We are getting closer and closer.·13.3.I don't see the problem. The obesity/diabetes area is gigantic, and we know the company is intensively negotiating possibilities for both specific and broad platform agreements with Novo and at least one other player of the same size. Nanexa is financed until 2026 and confident they will get an agreement - in the first half of the year as indicated by the chairman of the board. There isn't long left. The goal is the best achievable of its kind in a unique market that will finance the company for many years to come. This will start a journey towards Nanexa being in a completely, completely different league in a few years via their unique technology. Think about how low the market capitalization is currently.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 416 | - | - | ||
| 3 894 | - | - | ||
| 1 | - | - | ||
| 617 | - | - | ||
| 694 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 6.5.2025 | ||
2024 Q4 -tulosraportti 19.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
27 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 6.5.2025 | ||
2024 Q4 -tulosraportti 19.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenNanexa Discord is the only place this stock, to my knowledge, is discussed at a high and detailed level. And on an incredibly decent level. Thanks to our Swedish brother people for the good debate. If you want to debate, then write in English, it makes it easier and possibly use translate in your browser when reading. Danes are welcome - I myself have been incredibly well received. https://discord.com/channels/747545483072897115/
- ·1 päivä sittenDoes anyone know if there is a Nanexa discord or similar that is still alive?
- ·13.3. · MuokattuInteresting 6mdr chart. Up +50-60% from old level. A certain plateau it's hovering around in, 3,5-3,7 looks like the support one can somewhat count on. until it goes either UP or DOWN as soon as there's something new under the sun. Worst case, 3,5 cannot hold because in 1 mdr there's still no new information announced. Buuuut. Yes. It is is pure gambling to stand outside the door and wait for it to go up by itself.
- ·13.3.It could well indicate that news is coming soon, because the short sellers are covering their positions. Now the short interest has fallen from 0.36% yesterday, to 0.19% today.
- ·12.3.A little communication with the CEO below. All good things come to those who wait. ---------- Date: Thursday, 12 March 2026 at 09:00 To: David Westberg david.westberg@nanexa.se Subject: Sema-3-månaders-PK, BIO-Europe Hi David, Will you issue a press release when the sema-3-month results are ready, as you did with the 1-month results, and do you see that the meetings at BIO-Europe will mostly be discussions with some of the selected companies you are currently discussing GLP-1 with or new acquaintances? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 9:18 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, I expect that we will send out a PM about it when we have data. At BIO it will be mixed. Both old and new companies. Discussions about GLP-1 are taking place in parallel with BIO. Regards David ---------- Date: Thursday, 12 March 2026 at 09:58 To: David Westberg david.westberg@nanexa.se Subject: Re: Sema-3-månaders-PK, BIO-Europe Hi, Thanks, would you say that the GLP-1 discussions are progressing satisfactorily at present? Regards ---------- From: David Westberg david.westberg@nanexa.se Sent: Thursday, March 12, 2026 10:12 AM Subject: Re: Sema-3-månaders-PK, BIO-Europe I would, as I have previously communicated Regards David·13.3.Novo's former chairman is also impatient - but it's about getting a really good deal, not the fastest: https://www.youtube.com/watch?v=mg0B2L8fFtU&t=1228s We are getting closer and closer.·13.3.I don't see the problem. The obesity/diabetes area is gigantic, and we know the company is intensively negotiating possibilities for both specific and broad platform agreements with Novo and at least one other player of the same size. Nanexa is financed until 2026 and confident they will get an agreement - in the first half of the year as indicated by the chairman of the board. There isn't long left. The goal is the best achievable of its kind in a unique market that will finance the company for many years to come. This will start a journey towards Nanexa being in a completely, completely different league in a few years via their unique technology. Think about how low the market capitalization is currently.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 416 | - | - | ||
| 3 894 | - | - | ||
| 1 | - | - | ||
| 617 | - | - | ||
| 694 | - | - |
Välittäjätilasto
Dataa ei löytynyt